Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $11.6250 (-4.04%) ($11.6250 - $11.6250) on Sat. May. 1, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.01% (three month average) | RSI | 78 | Latest Price | $11.6250(-4.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1% a day on average for past five trading days. | Weekly Trend | BCRX advances 7.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting BCRX price | BCRX will decline at least -3.505% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.505% (StdDev 7.01%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $12.17(-4.48%) | 10 Day Moving Average | $11.95(-2.72%) | 20 Day Moving Average | $11.17(4.07%) | To recent high | -14.7% | To recent low | 26.4% | Market Cap | $N/A | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |